Drugs / MK-8510
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05700734 | Apr 2023 → Feb 2024 | HIV infectious disease | Merck Sharp & Dohme LLC | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK-8510 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05700734 ↗ |
| Route | Oral | “Single oral dose of MK-8510” NCT05700734 ↗ |